Singapore approves COVID-19 vaccine for use in 12 to 15-year-olds

Extend the interval between two-dose COVID-19 vaccines to six to eight weeks

  
A medical worker prepares a syringe at a coronavirus disease (COVID-19) vaccination center in Singapore March 8, 2021.

A medical worker prepares a syringe at a coronavirus disease (COVID-19) vaccination center in Singapore March 8, 2021.

Reuters/Edgar Su

SINGAPORE - Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old in a bid to extend protection to more groups as the country tackles a recent increase of infections, officials said on Tuesday.

"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding "its safety profile is also consistent with the known safety profile in the adult population".

The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.

(Reporting by Chen Lin in Singapore Editing by Ed Davies) ((LinChen1@thomsonreuters.com;))

More From Health